Global Babesiosis Market - Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Babesiosis Market

The Babesiosis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 5% in the above-mentioned research forecast period. Rise in foci transmission was found to be expanding causing rise on prevalence of Babesiosis which may motivate the Babesiosis market. 

Babesiosis is caused due to intra erythrocytic protozoan parasites, belonging to genus Babesia, infects red blood cells and is further spread by bite of infected ticks. Found commonly in animals and occasionally in humans. Signs of infections due to infected tick bite occur 8 weeks later, generally the infection is mild with flu such as symptoms, in severe cases due to parasitic multiplication symptoms such as haemolytic anemia, jaundice, haemoglobinuria and shortness of breath have been reported.

Human Babesiosis is an emerging infection for which numerous novel pharmacological compounds are being developed and are being evaluated for its treatment is bound to boost the market growth globally. The population of age fifty is more prone to this infection, rise in this particular age group population will also propel the global Babesiosis market. For the management of Babesiosis two microbial regimens namely atovaquone and azithromycin and the combination of quinine and clindamycin are found highly effective, which would have a positive impact on the market.

Available Babesiosis therapies are effective yet a need for vaccine exists, till date no vaccine is available for protection against Babesiosis which may have negative impact on the Babesiosis market. Limited chemotherapeutic choices are available along with less number of detection tests which are less reliable as well as slow may restrict market growth. Presence of many generic manufacturers may restraint market growth. Lack of any direct immunological diagnosis method for parasite antigen detection till date is a market restraint.

Splenectomised patients, immunocompromised, elderly and Lyme disease patients are at greater risk and babesiosis infection is life threating for these group of patients, death may occur within five to eight days of infection which is a challenge for the associated market. In cases where transmission occurs due to infected blood transfusion no test has been licensed yet for donor screening which is a challenge for the associated market.

Presence of effective treatment, and availability of varying treatment options is an opportunity for the market to grow. Novel immunological methods are under development which claim to be faster and more sensitive as compared to already available conventional methods which would give market an opportunity to prosper.

This Global Babesiosis Market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Babesiosis Market Scope and Market Size

The Babesiosis market is segmented on the basis of mode of transmission, diagnosis, symptoms, drug type, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

• On the basis of mode of transmission, the  Babesiosis market is segmented into ixodes scapularis ticks bite, contaminated blood transfusion and transmission from an infected mother to her baby
• On the basis of diagnosis, the Babesiosis market is segmented into parasitological methods, molecular methods and blood tests.
• On the basis of symptoms, the Babesiosis market is segmented into fever, body aches, haemolytic anaemia, thrombocytepenia, and abdominal pain.
• On the basis of drug type, the Babesiosis market is segmented into branded and generics.
• On the basis of route of administration, the Babesiosis market is segmented into oral, and injectable and others.
• On the basis of end-users, the Babesiosis market is segmented into hospitals, academic research institutes, home healthcare and others.
• On the basis of distribution channel, the Babesiosis market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Global Babesiosis Market Country Level Analysis

The Babesiosis market is analysed and market size information is provided by country, mode of transmission, diagnosis, symptoms, drug type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Global Babesiosis Market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the high healthcare expenditure and good quality medical facilities along with majority of population have insurance cover to claim this type of expensive treatment.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global Babesiosis Market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Babesiosis Market Share Analysis

 Babesiosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Babesiosis market.

The major players covered in the Babesiosis market report are GlaxoSmithKline LLC, Amneal Pharmaceuticals LLC., Apotex, Glenmark, Hetero, Lupin, Camber Pharmaceuticals, Inc., Galderma, Fresenius Kabi, Abott, Pfizer, Inc, Taro Pharmaceutical Industries, Otto Pharmaceutical, Medpharma, Endure Medical, Huajin Pharmaceutical, Mylan Pharmaceutical Inc., Tabuk Pharmaceutical, Aurobindo Pharma Ltd., and Epic Pharma LLC. Among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-60962